Cresco Labs' competition is printing gross profits between 60% - 65% on revenue. Management credits the efficiency improvements at these facilities in particular for an improvement in operational gross profit as a percentage of revenue coming in at 53% in the quarter, compared to 47% in the previous quarter. As of now, there is no information available about discounts or coupons. Receive CRLBF Stock News and Ratings via Email, March 1, 2023|markets.businessinsider.com. 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. And, as the company makes around half of its revenue from wholesale operations to other businesses, it doesn't necessarily need to maintain a large retail footprint to rake in cash. Cresco Labs has repeatedly proven its ability to seamlessly enter new markets, become operational, move products to market, and start taking market share faster than its competitors. We are looking for a driven Harvest Agent to join our growing team at Cresco Labs in Lincoln, IL. Cresco Labs has a net margin of -7.60% compared to SNDL's net margin of -53.71%. Most stock quote data provided by BATS. This is especially concerning because it enjoys a higher price point with its Remedi medicinal brand in comparison to its adult-use brands like Good News and its newest brand, High Supply. Cresco Labs's headquarters is located at 400 W Erie St Suite 110, Chicago. Each of its fellow MSOs. Its dividend yield is 3.2%, which is significantly higher, It had $2.5 billion in free cash flow at the end of the quarter, which will help fuel its growth strategies and dividend payouts, Medtronic's management also expects revenue growth to remain stable in the coming quarters as short-term headwinds fade. Each company is represented with a line over a 90 day period. The last few years have been difficult for Aurora Cannabis. Right now, Cresco is active in the majority of the largest cannabis markets in the U.S., including California, New York, Pennsylvania, and Massachusetts, and it's already planning to penetrate these markets more deeply. According to management, this strategy had a significant impact on its most recent quarterly results. Cresco Labs Inc. Market Cap. In the previous week, Cresco Labs had 5 more articles in the media than SNDL. This chart shows the average media sentiment of OTCMKTS and its competitors over the past 90 days as caculated by MarketBeat. Law360 (February 27, 2023, 6:40 PM EST) -- Cannabis giants Cresco Labs and Columbia Care will delay finalizing their planned $2 billion merger for three months, they announced . Cresco is built to become the most important company in the cannabis industry by combining the most strategic geographic footprint with one of the leading distribution platforms in North America. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. Dont let your products get skipped. Also, their cannabis and cannabis products are sourced domestically. In particular, its cultivation facilities in Illinois and Pennsylvania are becoming more efficient quite rapidly. Cresco Labs has excellent customer service and is very transparent. Making the world smarter, happier, and richer. If cannabis is legalized in the U.S., not all businesses will benefit. American Consumer News, LLC dba MarketBeat 2010-2023. Factset: FactSet Research Systems Inc.2019. . Cresco Labs was founded in 2013. From working with local government agencies to define appropriate regulations, to designing. This Cresco cannabis product was grown and harvested using environmentally friendly techniques and serious attention to detail, resulting in a better smoking experience. As growers, processors and retailers of premium cannabis operating in nine states, our company focuses on entering highly-regulatedmarkets with outsized demand potential and high barriers to entry. How to Decide, Taiwan Semiconductor Manufacturing Expanding in the West, One Way to Earn More From Dividend Stocks, How to Choose a Winning Dividend Investing Strategy, 3 Industries Leading the Stock Market Rebound, Oil Tankers Boost Dividends, See Continued Robust Business In '23. You can read more about your cookie choices at our privacy policyhere. Cresco carts hold 500 mg or 1 gram of liquid. Cresco Labs has a P/B Ratio of 0.62. Since its inception, Cresco has scaled its business better, but Trulieve is still going strong and enjoying much success. They have very high levels of THC, with the lowest just under 70 percent. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. When given a choice between these two, Cresco Labs seems a better buy. contact@marketbeat.com Let's examine an investment thesis for each to find out. The acquisition should close at the end of Q1 2023 and will add another 130 dispensaries to Cresco's portfolio. The top 10 competitors in Cresco Labs' competitive set are CGC, Aurora, Organigram, MariMed, Inc., Supreme Cannabis, MedReleaf, CannaCraft, Emerald Health, Cannasseur. Compare other stocks that are similar to CRLBF in performance, different metrics, and ratios. The Motley Fool owns shares of and recommends Cresco Labs Inc. and Trulieve Cannabis Corp. The shorties are pre-rolled marijuana cigarettes and weigh 0.5 grams. Pinterest has spent a lot of money to increase user engagement and attract more advertisers. With the addition of Harvest Health, Trulieve will have 155 retail outlets and operate in 11 states, giving it the most retail locations of any MSO. Aurora's path will not be easy unless the company generates profits and achieves positive cash flow. Standard & Poor's and S&P are registered trademarks of Standard & Poor's Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. Find company research, competitor information, contact details & financial data for EVOLUTIVE LABS CO., LTD. of Taipei City. However, the company's financials remain strong. Youre reading a free article with opinions that may differ from The Motley Fools Premium Investing Services. One share of CRLBF stock can currently be purchased for approximately $1.82. Cresco Labs, one of the nation's largest vertically integrated multistate cannabis operators, today announced it opened a new Sunnyside medical cannabis dispensary at. Despite not being a big name in the U.S. cannabis industry, Cresco Labs is slowly gaining traction through its nationwide network of 57 stores. Cresco Labs is a publicly-traded company currently managed by CEO Charlie Batchell. However, it also has the potential to make risk-tolerant investors wealthy in the long run with attractive investment options in both the Canadian and U.S. markets. Their plants are raised in in-door facilities to minimize the risk posed by insects and other pests. jane.doe@crescolabs.com), which is being used by 86.0% of Cresco Labs work email addresses. The acquisition should close at the end of Q1 2023 and will add another 130 dispensaries to Cresco's portfolio. Pinterest has spent a lot of money to increase user engagement and attract more advertisers. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Cresco Labs (CSE: CL) (OTCQX: CRLBF) is a medical cannabis cultivation and manufacturing company aimed at providing relief to patients in the United States. The Motley Fool has positions in and recommends Cresco Labs, Green Thumb Industries, and Trulieve Cannabis. Archived access to the webcast will be available for one year on the Cresco Labs . Yearly Gain. Additionally, they are not too highly-priced. Cresco Labs is one of the strongest players in the marijuana space compared to its Canadian peers. You'll now be able to see real-time price and activity for your symbols on the My Quotes of Nasdaq.com. Though the quarterly results appear to be encouraging, there are still some concerns. In Q4, global mobile app users increased by 14% year over year. The recovery of the ad market will boost Pinterest's growth even more. Description. 1 U.S. wholesaler of branded products, today announced its nationwide retail footprint hit 60 operating Sunnyside dispensaries through the opening of its newest stores in West Palm Beach and Winter Park, Florida. Their CRLBF share price forecasts range from $2.50 to $14.25. Name. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. Jim Halley (Trulieve): Trulieve is one of the best companies to invest in the cannabis space because the multi-state operator (MSO) knows how to make a profit and it's about to take advantage of its newfound size -- and resulting economies of scale. These products are lab tested and grown in Illinois and are available in Sativa, Indica, and Hybrid. That last question isn't a dealbreaker for me. The deal should close at the end of first quarter 2023 and will add another 130 dispensaries to Cresco's portfolio. SNDL has higher earnings, but lower revenue than Cresco Labs. Cresco Labs (CRLBF) Similar Stocks. Let's take a closer look to see if Aurora Cannabis (NASDAQ: ACB), a once-hot cannabis stock, or Cresco Labs, a U.S. multi-state operator (MSO), is a better . For general Cresco Labs inquiries: 312-929-0993 info@crescolabs.com . Top-flight products. SNDL presently has a consensus target price of $5.20, indicating a potential upside of 173.68%. Pinterest continues to be an innovative platform for bringing together small businesses from various industries and attracting more customers. Sign in to your free account to enjoy all that MarketBeat has to offer. Cannabis designed for you. The only criticism of this company is that they do not make enough CBD products. Precision Optics is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry. In-depth profiles and analysis for 20,000 public companies. Columbia's shares dived 52% this past year to $1.50. Aurora has no significant financial partners, unlike its peers. The new store is the Company's 26 th dispensary in the state . This cannabis can help users feel more energetic or relaxed, depending on whether they buy Indica or Hybrid. To make the world smarter, happier, and richer. Portfolio. When the symbol you want to add appears, add it to My Quotes by selecting it and pressing Enter/Return. Please note all regulatory considerations regarding the presentation of fees must be taken into account. Our trusted, national brands are available wholesale so that consumers can access them in as many places as possible. Making the world smarter, happier, and richer. Cresco Labs Celebrates New Sunnyside Dispensary Opening in South Orlando, Florida, Shop Legal Weed Now: New Stores Open In Two States And Canada, [BREAKING] New "Living Missile" to Replace Nuclear Missiles, Cresco Labs (OTCMKTS:CRLBF) Rating Lowered to Neutral at Piper Sandler, Cresco Labs Reaches 60 Nationwide Dispensaries with the Opening of Two Florida Stores, Cresco Labs (OTCMKTS:CRLBF) Earns "Overweight" Rating from Cantor Fitzgerald, Analysts Offer Insights on Materials Companies: Westlake Chemical (WLK) and Cresco Labs (OtherCRLBF), BREAKING: Tiny biotech successfully treats blindness, Alliance Global Partners Comments on Cresco Labs Inc.'s Q4 2022 Earnings (OTCMKTS:CRLBF), Cresco Labs Opens New Sunnyside Dispensary in Daytona Beach, Florida, Cresco Labs Expands Sunnyside in Pennsylvania with 11(th) New Store. Chocolate lovers are in luck, too. Assuming you're a cannabis cultivation company, that is. Looking ahead and and staying focused on a long-term vision can help to weather the storm of short-term headwinds and stock slumps. Copy and paste multiple symbols separated by spaces. Made with superior cultivation and harvesting, Mostly hybrid selections; one Indica and no Sativa. Cresco Labs stock has . As a result, anyone who invests in Cresco Labs stock now is likely to make significant gains. Pre-rolls are great for people who do not want to go through the trouble of rolling their own joints. Cresco is already profitable and commands a significantly larger market share in the U.S. Analysts on Wall Street believe Cresco's stock is a buy, with potential upside of 224% over the next 12 months. competitors and says it's the 'first minute of a new . Event: Cresco Labs Fourth Quarter and Full Year 2022 Earnings Conference Call. How to Decide, Taiwan Semiconductor Manufacturing Expanding in the West, One Way to Earn More From Dividend Stocks, How to Choose a Winning Dividend Investing Strategy, 3 Industries Leading the Stock Market Rebound, Oil Tankers Boost Dividends, See Continued Robust Business In '23. Company Overview. The company is also well-positioned for a successful 2023, with a strong balance sheet that closed 2022 with $2.7 billion in cash and cash equivalents. Get short term trading ideas from the MarketBeat Idea Engine. Backtested results are calculated by the retroactive application of a model constructed on the basis of historical data and based on assumptions integral to the model which may or may not be testable and are subject to losses. Real-time analyst ratings, insider transactions, earnings data, and more. This strategy weighed on its most recent quarterly results. They just revealed what they believe are the ten best stocks for investors to buy right now and Pinterest wasn't one of them! Invest better with The Motley Fool. *Average returns of all recommendations since inception. These companies are all part of the "medicinals & botanicals" industry. 9 Wall Street analysts have issued 1 year price targets for Cresco Labs' shares. CNSX:TER CA$809.3m. To see all exchange delays and terms of use please see Barchart's disclaimer. Management believes that the company's efforts in creating more personalized, timely, and engaging content are boosting its MAU and mobile app user growth. The company is on a mission to normalize, professionalize, and revolutionize cannabis. The formulation is meant to provide relief from inflammation and stress, and it can help the user rest more easily. The P/E ratio of Cresco Labs is -7.28, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The company's average rating score is 2.67, and is based on 6 buy ratings, 3 hold ratings, and no sell ratings. Currently, marijuana wholesaler Cresco Labs (CRLBF 0.55%) is living the dream. Now I bring people to vaping and bring vaping to people. They also sell whole flowers, concentrates, and pre-rolls. These are excellent products for vapers and e-nail users. The main competitors of Cresco Labs include SNDL (SNDL), biote (BTMD), Aurora Cannabis (ACB), Ascend Wellness (AAWH), Bright Green (BGXX), MariMed (MRMD), Cronos Group (CRON), Mind Medicine (MindMed) (MNMD), ChromaDex (CDXC), and Canopy Growth (CGC). Currently, Cresco distributes its products to several dispensaries and subsidiaries in the states mentioned above. With a decade of experience behind them, the Cresco Innovation team in the UK has an excellent track record of helping companies develop and implement innovation strategies. The Motley Fool->. Management has shown that it is effective at lowering costs, increasing sales revenue, and scaling production capacity keenly with demand. Specifically, backtested results do not reflect actual trading or the effect of material economic and market factors on the decision-making process. Both of these companies are well-structured and are likely to grow. Cresco Labs' stock was trading at $1.80 at the beginning of 2023. Cresco Labs provide both patients and doctors a "go-to" resource for research, products, and cannabis-based treatments. Growth like that could ebb over the next year and easily remain in the triple-digits. Cost basis and return based on previous market day close. General assumptions include: XYZ firm would have been able to purchase the securities recommended by the model and the markets were sufficiently liquid to permit all trading. Cresco's unparalleled speed to market was evident in Pennsylvania, where Cresco was not only the first cultivator approved and the first product to market, but . Compare Top Brokerages Here. These flowers are very well priced and are loaded with THC, and are mostly hybrids. Should I buy or sell Cresco Labs stock right now? Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. What is Cresco Labs's latest funding round? Cresco Labs keeps costs low by wholesaling marijuana where it's profitable to do so. Currently, marijuana wholesaler Cresco Labs (CRLBF 0.57%) . These new stores expand Cresco's Florida retail . Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. Feb. 18, 2021 at 8:42 a.m. As with any high-growth industry, there's no doubt investing in cannabis stocks today is risky business. The top 10 competitors average 1.5B. Zscaler, Inc Plummets, Is It Time To Buy The Dip? The vapes contain 300 mg of liquid and are available in Pride, Counting Sheep, Me Time, Brunch, Friyay, and Vegas. Based on an average daily volume of 871,100 shares, the short-interest ratio is currently 4.9 days. ET by Tomi Kilgore. The collection includes both "plant-touching" and "non-plant-touching" businesses. Data and analytics are essential when developing optimal strategies at each stage of production. On the other hand, Cresco is behind the learning curve with how to grow a lot of . As growers, processors and retailers of premium cannabis operating in nine states, our company focuses on entering. Cresco Labs trades on the OTCMKTS under the ticker symbol "CRLBF.". They offer Lime Sorbet (Indica) and Sour Pink Grapefruit (Sativa), and both are loaded with different cannabinoids like THC, THCA, and CBD. Cannabis legalization is sweeping over North America 19 states plus Washington, D.C., have all legalized recreational marijuana over the last few years, and full legalization came to Canada in October 2018. The company may benefit from the legalization of recreational cannabis in Pennsylvania. Cresco Labs is a medical cannabis cultivation company. Reaching millions of people each month through its website, books, newspaper column, radio show, television appearances, and subscription newsletter services, The Motley Fool champions shareholder values and advocates tirelessly for the individual investor. *Stock Advisor returns as of February 8, 2023. Job Description - Harvest Agent - with Great Benefits. February 23, 2023|americanbankingnews.com, November 29, 2022|markets.businessinsider.com. Zscaler, Inc Plummets, Is It Time To Buy The Dip? Will $2 billion merger of Cresco and Columbia Care reach the finish line? Buy These 2 Stocks in 2023 and Hold for the Next Decade, 2 Stocks That Are About to Make Their Shareholders Richer, Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research, Motley Fool Issues Rare All In Buy Alert, earnings before interest, taxes, depreciation, and amortization (EBITDA), Copyright, Trademark and Patent Information. But it also has a successful retail model, which is steadily bringing in more and more annual sales per store with every year. View analysts price targets for CRLBF or . When the symbol you want to add appears, add it to Watchlist by selecting it and pressing Enter/Return. As of December 6, 2022, it owned and operated 55 dispensaries. In addition, they come in different flavors: Florical Farms has several types of dry bud, like Lime Sorbet, Julius 2.0, and countless other strains. Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Beyond the requirements of industry regulation, we regulate ourselves to a higher standard because its the right thing to do. About Cresco Labs Inc. Cresco Labs is one of the largest vertically integrated multistate cannabis operators in the United States, with a mission to normalize and professionalize the cannabis industry. 9 equities research analysts have issued 12-month target prices for Cresco Labs' shares. Buy These 2 Stocks in 2023 and Hold for the Next Decade, 2 Stocks That Are About to Make Their Shareholders Richer, Join Over Half a Million Premium Members And Get More In-Depth Stock Guidance and Research, Copyright, Trademark and Patent Information. But Cresco is about to get bigger after completing the acquisition of Columbia Care. Customers can buy flowers, live resin, concentrates, and pre-rolls. . This suggests a possible upside of 276.8% from the stock's current price. 10.7% of SNDL shares are held by institutional investors. Total revenue in the third quarter of fiscal 2023 (ended Jan. 27) was flat versus the prior-year quarter at $7.7 billion. Raw Cones: 100 Percent Natural Rolling Papers. Learn more. The company employs 3,500 workers across the globe. So, on the one hand, companies can achieve these levels. Based on Macroaxis valuation methodology, the firm appears to be overvalued. CHICAGO, February 27, 2023--Cresco Labs & Columbia Care Mutually Extend Acquisition Closing Timeline; Cresco to Report Fourth Quarter & Full Year 2022 Earnings March 16, 2023 Event: Cresco Labs Fourth Quarter and Full Year 2022 Earnings Conference Call. This chart shows the number of new MarketBeat users adding CRLBF and its top 5 competitors to their watchlist. This MSO has stronger fundamentals than Aurora Cannabis. Trulieve was already the biggest cannabis company in Florida, but the Harvest deal makes it the market leader in Arizona, with 16 dispensaries there and plans for 20, and in Pennsylvania, where it has 19 dispensaries. Please log in to your account or sign up in order to add this asset to your watchlist. Follow. Comparatively, 0.2% of Cresco Labs shares are held by institutional investors. Time: 8:30 am EST. As a team, we have raised 30 million in funding in three years, and in 2017 alone we secured 18 million for European SMEs. As the marijuana industry experiences rising business competition from a wave of legalization in the U.S., it may not be able to defend its medicinal market share against others as a result. All Rights Reserved. Competition within the industry is rising, and Cresco still isn't listed on any U.S. stock exchange. Sign-up to receive the latest news and ratings for Cresco Labs and its competitors with MarketBeat's FREE daily newsletter. Analyst Briefing Submitters are 7x more likely to receive a qualified connection. However, Pinterest has proven investors wrong with its recent quarterly results. Cresco is currently trading for $1.74 and is valued at 0.61 times sales, indicating that it is likely undervalued and making now an excellent time to buy. I love using new gear, writing in-depth reviews and generally nerding out about vaping to like-minded people. CBI websites generally use certain cookies to enable better interactions with. Cresco Labs's revenue is the ranked 1st among it's top 10 competitors. OTTAWA, Jan. 6, 2020 /CNW/ - CannaRoyalty Corp. d/b/a Origin House(CSE: OH)(OTCQX: ORHOF) ("Origin House"or the"Company"), a North American cannabis products and brands company, is pleased to announce, further to the Company's press releases dated April 1, 2019 and November 13, 2019, that the Company has obtained a final order from the Ontario . View which stocks are hot on social media with MarketBeat's trending stocks report. Disclaimer. This means that Cresco cannabis is free of pesticides, chemicals, and other substances that detract from this plants health benefits. If you have shopped with Cresco or invested in Cresco Labs stock, let us know about your results. The company derives 59% of its revenue from wholesale transactions, which is significantly more than its primary competitors like Curaleaf. Nearly 400 Cannabis Workers Joined The Union Since Jan. 1st, 2 Cannabis Stocks to Buy and 1 to Avoid in 2023, Down 70%: 2 Growth Stocks Are Smart Buys in a Bear Market, Why Green Thumb Industries, Curaleaf, and Cresco Labs Rallied Today, Why Green Thumb Industries, Curaleaf, and Cresco Labs Plunged Today, Cresco Labs Expands Retail Presence in Orlando, Florida, Cannabis stocks slide after Senator McConnell rebukes marijuana legislation, Cannabis stocks move after President Biden signs marijuana research bill, Wedbush initiates four cannabis stocks with outperform ratings and Green Thumb Industries as top tick, Top Marijuana MSOs Amid Earnings Season: Analyst Shares Key Takeaways From Q3 Reports & What They Mean, Good Stocks To Buy Right Now? Demand-supply imbalances in Canada affected revenue, compounding Aurora's problems. The vast majority of publicly traded pot stocks lost more than half of their value in 2022 as high inflation, growing competition, and a lack of cannabis reform on Capitol Hil. 2 Best Cannabis Stocks to Buy for February, 3 Cannabis Companies To Watch if Ohio Approves Adult-Use Cannabis Sales, Down 70%: 2 Growth Stocks Are Smart Buys in a Bear Market, 2 Marijuana Stocks That Could Be the Best Bargains of 2023, 2 Reasons to Avoid a Roth 401(k) for Your Retirement Savings, Warren Buffett's Latest $2.9 Billion Buy Brings His Total Investment in This Stock to $66 Billion in 4 Years, Want $1 Million in Retirement? View analysts price targets for CRLBF or view top-rated stocks among Wall Street analysts. MarketBeat recorded 12 mentions for Cresco Labs and 2 mentions for SNDL. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. His legal expertise and extensive experience in this industry have allowed the company to navigate various regulatory obstacles while maintaining steady growth. After repeatedly failing to meet its target of positive EBITDA, the company's recent quarterly results provided a ray of hope. If Allied Market Research's estimates are correct, the global cannabis market could reach $149 billion by 2031. Top Stocks. Grown by CRESCO LABS. The company is also well-positioned for a successful 2023, with a strong balance sheet that closed 2022 with $2.7 billion in cash and cash equivalents. Our daily ratings and market update email newsletter. These companies have a lot of potential, and Cresco has done a great job scaling its business and is geographically well-positioned to take advantage of legalization, which will happen eventually. We will compare the two businesses based on the strength of their institutional ownership, profitability, dividends, valuation, analyst recommendations, media sentiment, risk, earnings and community ranking. Who is the CEO of Cresco labs? Merging with Columbia may push it to the forefront of the industry as competition heats up. This brand contains Crescos best harvest. They have options for Sativa and Indica, and they are available at varying prices. SNDL (NASDAQ:SNDL) and Cresco Labs (OTCMKTS:CRLBF) are both small-cap medical companies, but which is the superior business? Select Columns. Furthermore, Cresco competes in the medicinal and recreational cannabis markets, but its portfolio of adult use brands is far larger than its medicinal holdings. They specialize in making glass bongs, bubblers, and one-hitters. Get daily stock ideas from top-performing Wall Street analysts. The company saw Hugo garner positive sales momentum in global markets, according to management. Cresco Cannabis. Alex Carchidi (Cresco Labs): In my view, Cresco Labs is a good choice for investors who are looking for a cannabis company that's making progress in multiple areas at once. But compared to companies like Aurora Cannabis, it's much closer to consistently profitable operations. There are currently 3 hold ratings and 6 buy ratings for the stock. Cresco Labs, LLC develops medical marijuana facility to provide medical products for patients. Cresco currently operates 11 dispensaries in Pennsylvania, five in Ohio, and 22 in Florida. View which stocks are hot on social media with MarketBeat's trending stocks report.